These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31261818)

  • 41. Differentiation-inducing factor-3 inhibits intestinal tumor growth in vitro and in vivo.
    Kubokura N; Takahashi-Yanaga F; Arioka M; Yoshihara T; Igawa K; Tomooka K; Morimoto S; Nakatsu Y; Tsuzuki T; Nakabeppu Y; Matsumoto T; Kitazono T; Sasaguri T
    J Pharmacol Sci; 2015 Apr; 127(4):446-55. PubMed ID: 25913757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. KR-33028, a potent inhibitor of the Na
    Amith SR; Wilkinson JM; Fliegel L
    Biochem Pharmacol; 2016 Oct; 118():31-39. PubMed ID: 27521504
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-leukemic activities of Dictyostelium secondary metabolites: a novel aromatic metabolite, 4-methyl-5-n-pentylbenzene-1,3-diol, isolated from Dictyostelium mucoroides suppresses cell growth in human leukemia K562 and HL-60 cells.
    Kikuchi H; Oshima Y; Ichimura A; Gokan N; Hasegawa A; Hosaka K; Kubohara Y
    Life Sci; 2006 Dec; 80(2):160-5. PubMed ID: 17027864
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway.
    Wu C; Qiu S; Liu P; Ge Y; Gao X
    J Ethnopharmacol; 2018 Jan; 211():89-100. PubMed ID: 28962890
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DIF-1, morphogen of Dictyostelium discoideum, induces the erythroid differentiation in murine and human leukemia cells.
    Asahi K; Sakurai A; Takahashi N; Kubohara Y; Okamoto K; Tanaka Y
    Biochem Biophys Res Commun; 1995 Mar; 208(3):1036-9. PubMed ID: 7702602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Repurposing mebendazole against triple-negative breast cancer CNS metastasis.
    Rodrigues AJ; Chernikova SB; Wang Y; Trinh TTH; Solow-Cordero DE; Alexandrova L; Casey KM; Alli E; Aggarwal A; Quill T; Koegel AK; Feldman BJ; Ford JM; Hayden-Gephart M
    J Neurooncol; 2024 May; 168(1):125-138. PubMed ID: 38563850
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DIF-1, putative morphogen of D. discoideum, suppresses cell growth and promotes retinoic acid-induced cell differentiation in HL-60.
    Kubohara Y
    Biochem Biophys Res Commun; 1997 Jul; 236(2):418-22. PubMed ID: 9240452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal-epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs.
    Manupati K; Dhoke NR; Debnath T; Yeeravalli R; Guguloth K; Saeidpour S; De UC; Debnath S; Das A
    FEBS J; 2017 Jun; 284(12):1830-1854. PubMed ID: 28398698
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Triptolide Decreases Cell Proliferation and Induces Cell Death in Triple Negative MDA-MB-231 Breast Cancer Cells.
    Varghese E; Samuel SM; Varghese S; Cheema S; Mamtani R; Büsselberg D
    Biomolecules; 2018 Dec; 8(4):. PubMed ID: 30563138
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer.
    Kim YJ; Choi JS; Seo J; Song JY; Lee SE; Kwon MJ; Kwon MJ; Kundu J; Jung K; Oh E; Shin YK; Choi YL
    Int J Cancer; 2014 May; 134(10):2424-36. PubMed ID: 24615768
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Derivatives of Differentiation-Inducing Factor 1 Differentially Control Chemotaxis and Stalk Cell Differentiation in
    Kuwayama H; Kikuchi H; Kubohara Y
    Biology (Basel); 2023 Jun; 12(6):. PubMed ID: 37372157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dictyostelium differentiation-inducing factor-1 induces glucose transporter 1 translocation and promotes glucose uptake in mammalian cells.
    Omata W; Shibata H; Nagasawa M; Kojima I; Kikuchi H; Oshima Y; Hosaka K; Kubohara Y
    FEBS J; 2007 Jul; 274(13):3392-404. PubMed ID: 17553062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The putative morphogen, DIF-1, of Dictyostelium discoideum activates Akt/PKB in human leukemia K562 cells.
    Kubohara Y; Hosaka K
    Biochem Biophys Res Commun; 1999 Oct; 263(3):790-6. PubMed ID: 10512759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.
    Vázquez R; Riveiro ME; Astorgues-Xerri L; Odore E; Rezai K; Erba E; Panini N; Rinaldi A; Kwee I; Beltrame L; Bekradda M; Cvitkovic E; Bertoni F; Frapolli R; D'Incalci M
    Oncotarget; 2017 Jan; 8(5):7598-7613. PubMed ID: 27935867
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel compound LingH2-10 inhibits the growth of triple negative breast cancer cells in vitro and in vivo as a selective inverse agonist of estrogen-related receptor α.
    Ning Y; Chen H; Du Y; Ling H; Zhang L; Chen L; Qi H; Shi X; Li Q
    Biomed Pharmacother; 2017 Sep; 93():913-922. PubMed ID: 28715872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apatinib enhanced anti-tumor activity of cisplatin on triple-negative breast cancer through inhibition of VEGFR-2.
    Gao Z; Shi M; Wang Y; Chen J; Ou Y
    Pathol Res Pract; 2019 Jul; 215(7):152422. PubMed ID: 31079851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differentiation inducing factor 3 mediates its anti-leukemic effect through ROS-dependent DRP1-mediated mitochondrial fission and induction of caspase-independent cell death.
    Dubois A; Ginet C; Furstoss N; Belaid A; Hamouda MA; El Manaa W; Cluzeau T; Marchetti S; Ricci JE; Jacquel A; Luciano F; Driowya M; Benhida R; Auberger P; Robert G
    Oncotarget; 2016 May; 7(18):26120-36. PubMed ID: 27027430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis.
    Jin K; Pandey NB; Popel AS
    Breast Cancer Res; 2018 Jun; 20(1):54. PubMed ID: 29898755
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    Hirayama A; Ishigaki H; Takahashi K; Miura Y; Kikuchi H; Kubohara Y
    Juntendo Iji Zasshi; 2023; 69(2):105-115. PubMed ID: 38854456
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition
    Yu JK; Yue CH; Pan YR; Chiu YW; Liu JY; Lin KI; Lee CJ
    Anticancer Res; 2018 Apr; 38(4):2127-2135. PubMed ID: 29599331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.